Recombinant Human CCR8 Protein，His

CCR8 (C-C chemokine receptor type 8) is a chemokine receptor that plays a significant role in immune system regulation, particularly in the migration and activation of various immune cell types, including T-cells and regulatory T-cells. Its involvement in immune responses makes it a relevant target for studying diseases such as asthma, autoimmune disorders, and cancer. CCR8 is known to bind specific chemokines, thereby influencing the recruitment of immune cells to sites of inflammation. Understanding the structure and function of CCR8 is critical for developing therapeutic strategies aimed at modulating immune responses. Recent advances in recombinant protein technology have enabled researchers to produce and study CCR8 as a recombinant protein, allowing for detailed investigations of its binding properties, signaling pathways, and potential as a drug target. The recombinant CCR8 protein can be utilized in various assays to explore its interactions with ligands and inhibitors, which is instrumental in drug discovery processes. Additionally, as CCR8 is expressed on certain tumor-infiltrating lymphocytes, studying its role may provide insights into the tumor microenvironment and aid in the development of immunotherapies. Overall, research on CCR8 and its recombinant variants holds promise for advancing our understanding of immune regulation and developing novel treatments for immune-related diseases.